Daratumumab - CaLiGraph

CaLiGraph

Property	Value
rdf:type	owl:NamedIndividual Orphan drug Therapeutic monoclonal antibody Johnson & Johnson brand Johnson & Johnson products and services Monoclonal antibody for tumors Drug granted breakthrough therapy designation Antineoplastic and immunomodulating drug
rdfs:label	Daratumumab
owl:sameAs	dbr:Daratumumab
prov:wasDerivedFrom	http://en.wikipedia.org/wiki/Category:Johnson_&_Johnson_brands http://en.wikipedia.org/wiki/List_of_Johnson_&_Johnson_products_and_services http://en.wikipedia.org/wiki/Category:Antineoplastic_and_immunomodulating_drugs http://en.wikipedia.org/wiki/Category:Orphan_drugs http://en.wikipedia.org/wiki/List_of_drugs:_D%E2%80%93Dd http://en.wikipedia.org/wiki/List_of_therapeutic_monoclonal_antibodies http://en.wikipedia.org/wiki/Multiple_myeloma http://en.wikipedia.org/wiki/Genmab http://en.wikipedia.org/wiki/Monoclonal_antibody_therapy http://en.wikipedia.org/wiki/List_of_drugs_granted_breakthrough_therapy_designation http://en.wikipedia.org/wiki/CD38 http://en.wikipedia.org/wiki/Category:Monoclonal_antibodies_for_tumors
skos:prefLabel	Daratumumab
skos:altLabel	DARZALEX Darzalex daratumumab
clgo:alternativeName	Darzalex
clgo:casNumber	945721-28-8
clgo:chEMBL	1743007
clgo:drugbank	DB09331
clgo:fdaUniiCode	4Z63YK6E0E
clgo:kegg	D10777
clgo:medlinePlus	a616002
is clgo:product of	Genmab

About: clgr:Daratumumab